Salmon-derived thrombin inhibits development of chronic pain through an endothelial barrier protective mechanism dependent on APC

Biomaterials. 2016 Feb:80:96-105. doi: 10.1016/j.biomaterials.2015.11.062. Epub 2015 Dec 2.

Abstract

Many neurological disorders are initiated by blood-brain barrier breakdown, which potentiates spinal neuroinflammation and neurodegeneration. Peripheral neuropathic injuries are known to disrupt the blood-spinal cord barrier (BSCB) and to potentiate inflammation. But, it is not known whether BSCB breakdown facilitates pain development. In this study, a neural compression model in the rat was used to evaluate relationships among BSCB permeability, inflammation and pain-related behaviors. BSCB permeability increases transiently only after injury that induces mechanical hyperalgesia, which correlates with serum concentrations of pro-inflammatory cytokines, IL-7, IL-12, IL-1α and TNF-α. Mammalian thrombin dually regulates vascular permeability through PAR1 and activated protein C (APC). Since thrombin protects vascular integrity through APC, directing its affinity towards protein C, while still promoting coagulation, might be an ideal treatment for BSCB-disrupting disorders. Salmon thrombin, which prevents the development of mechanical allodynia, also prevents BSCB breakdown after neural injury and actively inhibits TNF-α-induced endothelial permeability in vitro, which is not evident the case for human thrombin. Salmon thrombin's production of APC faster than human thrombin is confirmed using a fluorogenic assay and APC is shown to inhibit BSCB breakdown and pain-related behaviors similar to salmon thrombin. Together, these studies highlight the impact of BSCB on pain and establish salmon thrombin as an effective blocker of BSCB, and resulting nociception, through its preferential affinity for protein C.

Keywords: Activated protein C; Blood–brain barrier; Nerve root injury; Pain; Thrombin.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Capillary Permeability / drug effects
  • Chronic Pain / blood
  • Chronic Pain / drug therapy*
  • Chronic Pain / immunology
  • Chronic Pain / pathology
  • Cytokines / blood
  • Cytokines / immunology
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / immunology
  • Endothelium, Vascular / pathology
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Hyperalgesia / blood
  • Hyperalgesia / drug therapy*
  • Hyperalgesia / immunology
  • Hyperalgesia / pathology
  • Inflammation / blood
  • Inflammation / drug therapy
  • Inflammation / immunology
  • Inflammation / pathology
  • Male
  • Models, Molecular
  • Molecular Sequence Data
  • Protective Agents / chemistry
  • Protective Agents / isolation & purification
  • Protective Agents / therapeutic use*
  • Protein C / immunology*
  • Rats
  • Salmon / metabolism
  • Spinal Cord / blood supply*
  • Spinal Cord / drug effects
  • Spinal Cord / immunology
  • Spinal Cord / pathology
  • Thrombin / chemistry
  • Thrombin / isolation & purification
  • Thrombin / therapeutic use*

Substances

  • Cytokines
  • Protective Agents
  • Protein C
  • Thrombin